It is good for you, as parents throughout the ages have said — so good, in fact, that broccoli could yield a cancer breakthrough.
Evgen Pharma, a five-person start-up in Liverpool, is hoping to raise £20 million through the Alternative Investment Market, which could value the business at £40 million.
It wants to use the money for clinical trials of sulforaphane, a substance commonly found in broccoli and other brassica vegetables, and hopes to use a synthetic version to treat prostate cancer, breast cancer and certain types of stroke.
Barry Clare, the chairman of Evgen, said: “Back in the Seventies, there were lots of studies suggesting that people who ate a lot of brassica vegetables had a lower incidence of cancer.”
The problem, since then,